The findings are the result of an analysis of more than 13,000 imaging reports containing additional follow-up recommendations.

Bob Still, executive director of the Radiologist Business Management Association, believes CMS’s proposed physician fee schedule for 2023 will harm vulnerable populations and seriously injure U.S. healthcare. Hear him out.

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

Radiology researchers from six leading medical schools have laid out some attuned and readily adoptable strategies for groups challenged to prosper in a time of difficult reimbursement dynamics.

Within hours of Amazon announcing its intention to acquire healthcare provider One Medical for $3.9 billion in cash, lawmakers took aim at the retail giant to pursue blocking the deal.

Women who skipped screening due to financial concerns outnumbered those who were not screened due to logistical issues such as scheduling and transportation conflicts, new survey data reveals. 

Two weeks ago CMS proposed a 2023 physician fee schedule (PFS) that stands to slash pay to U.S. diagnostic radiologists by 3% and interventionalists by 4%. This week the U.K.’s National Health Service put that country’s radiologists in a similar bind.

Bracco Diagnostics, Inc has been given the go ahead by the U.S. Food and Drug Administration to temporarily import Iomeron (iomeprol injection) into the U.S. market amid the ongoing iodinated contrast media shortage.